https://www.selleckchem.com/
Relative risk and 95% CI werecalculated using logistic regression coefficients. 144 patients were analyzed, 87 were treated with mycophenolatemofetil and 57 received mycophenolate mofetil and valganciclovirtogether. An overall risk of neutropenia of 37% [95% CI (29- 45)] wasobserved. The risk was significantly higher in patients who received thecombination of mycophenolate mofetil and valganciclovir (56%) than inthose treated with mycophenolate mofetil alone (24%), p = 0.001. Binarylogistic-regression analysis revealed that concomitant use of mycophenolatem
Like
Comment
Share
